Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>
2024 · Journal of Clinical Oncology · 167 citations
https://doi.org/10.1200/jco.23.02474
H
Hirohisa Nakamae
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
480
Papers
8.7K
Citations
37
h-index
147
i10-index
Hirohisa Nakamae is an academic researcher from Osaka City University. The author has contributed to research in topics: Hematopoietic Stem Cell Transplantation & Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments. The author has an h-index of 37, co-authored 408 publications.
ORCID: 0000-0003-4203-990XPapers by this author
worksEffect of Conditioning Regimen Intensity on CMV Infection in Allogeneic Hematopoietic Cell Transplantation
2009 · Biology of Blood and Marrow Transplantation · 79 citations
https://doi.org/10.1016/j.bbmt.2009.02.009
Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma
2009 · Journal of Experimental & Clinical Cancer Research · 65 citations
https://doi.org/10.1186/1756-9966-28-116
ENESTnd Update: Nilotinib (NIL) Vs Imatinib (IM) In Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP) and The Impact Of Early Molecular Response (EMR) and Sokal Risk At Diagnosis On Long-Term Outcomes
2013 · Blood · 47 citations
https://doi.org/10.1182/blood.v122.21.92.92
Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes
2020 · Bone Marrow Transplantation · 46 citations
https://doi.org/10.1038/s41409-020-01163-z
An enterococcal phage-derived enzyme suppresses graft-versus-host disease
2024 · Nature · 37 citations
https://doi.org/10.1038/s41586-024-07667-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat